Add BrightSurf on Google Email

Study points to potential misuse/abuse of ADHD drugs

A study published in the British Journal of Clinical Pharmacology suggests that methylphenidate, an ADHD medication, may be subject to misuse and/or abuse. The study found inconsistent patterns of use among adult users, particularly those aged 25-49 years.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateMar 7, 2018

Illicit drug use may affect sexual function in men

A study of 1159 males who illicitly used amphetamines found that half reported no impact on sexual functions, while the other half experienced reduced erectile rigidity, enhanced orgasmic intensity, and delayed ejaculation. Amphetamine users were also twice as likely to experience erectile dysfunction compared to matched controls.

SourceWiley·JournalThe Journal of Sexual Medicine·DateJul 6, 2015

Is the gut microbiome a potential cause and therapeutic target for autoimmune diseases like multiple sclerosis?

Researchers explore the link between gut microbiome and autoimmune disorders like multiple sclerosis, highlighting potential therapeutic targets. The study suggests that the gut microbiome plays a crucial role in immune cell activity and cytokine production, which may impact susceptibility to and treatment of autoimmune diseases.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalJournal of Interferon & Cytokine Research·DateAug 7, 2014

Gene therapy treatment extends lives of mice with fatal disease, MU study finds

Researchers at the University of Missouri have developed a gene therapy treatment that extends the lives of mice with spinal muscular atrophy by introducing a missing gene into their central nervous systems. This breakthrough offers new hope for treating humans with SMA, potentially providing a cure within 12-18 months.

SourceUniversity of Missouri-Columbia·JournalBiochemical and Biophysical Research Communications·DateJul 16, 2012

Leading Minds of tomorrow, rewarded today

Three exceptional researchers have been awarded the Young Minds in CNS Award for their innovative work on residual symptoms in bipolar disorder, serotonin receptors in anxiety disorders, and thalamic neurochemistry in schizophrenia. The $20,000 award will support career development and attendance at international congresses.